Page last updated: 2024-09-03

n,n-dimethylarginine and Cystic Fibrosis

n,n-dimethylarginine has been researched along with Cystic Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, E; Da Dalt, L; Giordano, G; Gucciardi, A; Lucca, F; Naturale, M; Perilongo, G; Pirillo, P; Ros, M1
Al-Saleh, S; Amin, R; Belik, J; Grasemann, H; Mehl, A; Pencharz, P; Rafii, M; Ratjen, F; Scott, JA; Shehnaz, D1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Cystic Fibrosis

ArticleYear
Asymmetric dimethylarginine and related metabolites in exhaled breath condensate of children with cystic fibrosis.
    The clinical respiratory journal, 2018, Volume: 12, Issue:1

    Topics: Adolescent; Arginine; Biomarkers; Breath Tests; Child; Chromatography, High Pressure Liquid; Cystic Fibrosis; Disease Progression; Exhalation; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mass Spectrometry; Prospective Studies

2018
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.
    American journal of respiratory and critical care medicine, 2011, May-15, Volume: 183, Issue:10

    Topics: Adolescent; Airway Obstruction; Arginine; Child; Chromatography, Liquid; Cystic Fibrosis; Female; Humans; Lung; Male; Nitric Oxide; Respiratory System; Sputum; Tandem Mass Spectrometry

2011